New weight-loss pill has arrived in Israel: Everything you need to know
Global pharmaceutical company Eli Lilly launched "Orforglipron" in Israel this week, a new daily pill designed for weight loss. This is significant news for many patients, as unlike existing treatments on the market, the new medication is administered orally rather than through an injection.
The medication is intended for people suffering from overweight or obesity, and its goal is to assist in the weight-loss process in a more convenient way. According to the company's announcements, the monthly price for the treatment will start at 691 shekels. This is a competitive move in the weight-loss drug market, which has been growing very rapidly in recent years.
Use of the pill requires personalization by a specialist physician. As with any new medication, it is important to be aware of potential side effects and precise medical guidelines before beginning use. Patients are required to undergo regular medical monitoring to ensure that the treatment is safe and effective for them.
The entry of "Orforglipron" into Israel marks a change in the way patients approach obesity treatment. While in the past pharmacological treatments were based primarily on weekly injections, the daily pill offers a more accessible and simpler solution for many. Health experts recommend combining the drug treatment with a healthy lifestyle, including a balanced diet and regular physical activity.